Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine
Yale University
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Massachusetts General Hospital
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
Ruijin Hospital
University of Miami
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
Northwestern University
Fred Hutchinson Cancer Center